Introduction
Gene editing technologies have revolutionized our approach to treating genetic disorders. The CRISPR-Cas9 system, in particular, has emerged as a powerful tool for precise genomic modifications. However, concerns about off-target effects and editing efficiency have limited its therapeutic applications.
Methods
We developed a modified guide RNA scaffold that enhances specificity while maintaining high editing efficiency. Human embryonic stem cells were cultured under standard conditions and subjected to our optimized CRISPR-Cas9 protocol.
Results
Our modified approach achieved a 94% editing efficiency with a significant reduction in off-target mutations. Whole genome sequencing confirmed the precision of our modifications across multiple cell lines.
Discussion
These findings represent a significant advancement in gene editing technology. The improved precision and efficiency of our approach could accelerate the development of gene therapies for conditions such as sickle cell disease, cystic fibrosis, and muscular dystrophy.
Conclusion
Our optimized CRISPR-Cas9 protocol demonstrates that high-precision gene editing in human stem cells is achievable, paving the way for safer and more effective therapeutic interventions.
